Anders Bach

Anders Bach earned his PhD in medicinal chemistry from University of Copenhagen in 2009. His research on peptidomimetic inhibitors for CNS led to a spinout company and clinical development. After a postdoc at the Italian Institute of Technology, he established his group at the University of Copenhagen in 2016, focusing on fragment-based drug discovery against protein-protein interaction targets involved in oxidative stress and inflammation. He was appointed professor in medicinal chemistry in 2023.